Evaluating New Mexico's Recidivism Reduction Program (RRP)

April 6, 2018 updated by: Pepperdine University

Evaluating New Mexico's Prison-Based Recidivism Reduction Program

A a multi-site trial to measure the efficacy of the Recidivism Reduction Program, a prison based, twenty-one module reentry program operated by the New Mexico Department of Corrections.

Study Overview

Detailed Description

The New Mexico Department of Corrections Recidivism Reduction Program (RRP) is designed to provide offenders with knowledge and skills that are transferable to the community setting and to address issues that offenders will invariably face upon release to the community. Transitional coping skills, offender expectations upon release, family issues, and dealing with authority figures are a few of the challenges facing offenders upon reintegration. The Recidivism Reduction Program is aimed at preparing offenders for the potential obstacles that they may encounter upon release to the community and providing them skills to overcome the challenges that they will face. The RRP curriculum focuses on belief systems, self-esteem, and rational thinking. The RRP is a twenty-one module clinician-led program (approximately 100 hours) delivered in a group setting within months of release. Outcomes focus on measures of transition readiness, successful transition into the community, and recidivism.

Study Type

Interventional

Enrollment (Actual)

159

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • New Mexico
      • Grants, New Mexico, United States, 87020
        • Western New Mexico Correctional Facility (WNMCF)
      • Los Lunas, New Mexico, United States, 87031
        • Central New Mexico Correctional Facility (CNMCF)
      • Santa Fe, New Mexico, United States, 87504
        • Penitentiary of New Mexico (PNM)
      • Springer, New Mexico, United States, 87747
        • Springer Correctional Facility (SCF)

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

Male

Description

Inclusion Criteria:

  • Inmates who have six months prior to release
  • Inmates housed at one of the four experimental prisons
  • Inmates willing to participate in the Recidivism Reduction Program

Exclusion Criteria:

- Housed in security Level 4 or 5

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Recidivism Reduction Program
Inmates who were assigned to the RRP intervention.
Assigned to the 21-module Recidivism Reduction Program
Other Names:
  • RRP
  • Mew Mexico RRP
  • New MExico Recidivism Reduction Program
Active Comparator: Business-as-usual
Business-as-usual are those inmates not assigned to RRP and who receive standard inmate programming.
Inmates who receive standard programming offered by New Mexico Department of Corrections prior to release.
Other Names:
  • Control group

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Revocation rate
Time Frame: 12 months
Percentage of subjects in each condition who are revoked from parole and returned to prison during the 12 months following their initial release.
12 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Days incarcerated
Time Frame: 12 months
Total number of days incarcerated in jail or prison after initial release.
12 months
New arrests
Time Frame: 12 months
Number of new arrests in the 12 months following initial release.
12 months
Self esteem
Time Frame: 2 months
Inmate score on self-reported self esteem scale at two-month followup (just prior to release from prison).
2 months
Drug use self efficacy
Time Frame: 2 months
Inmate score on self reported drug use self efficacy scale at 2 months followup (just prior to release from prison).
2 months
Criminal thinking
Time Frame: 2 months
Inmate score on self reported criminal thinking scale at two month followup (just prior to release from prison).
2 months
Depression
Time Frame: 2 months
Inmates score on self reported depression scale at 2 month followup (just prior to release from prison).
2 months
Anxiety
Time Frame: 2 months
Inmates score on self reported anxiety scale at 2 month followup (just prior to release from prison).
2 months
Hostility
Time Frame: 2 months
Inmates score on self reported hostility scale at 2 month followup (just prior to release from prison).
2 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

March 1, 2011

Primary Completion (Actual)

March 1, 2012

Study Completion (Actual)

May 1, 2012

Study Registration Dates

First Submitted

May 18, 2011

First Submitted That Met QC Criteria

May 19, 2011

First Posted (Estimate)

May 20, 2011

Study Record Updates

Last Update Posted (Actual)

April 10, 2018

Last Update Submitted That Met QC Criteria

April 6, 2018

Last Verified

April 1, 2018

More Information

Terms related to this study

Other Study ID Numbers

  • SPP0311F07

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Behavior

Clinical Trials on Recidivism Reduction Program

Subscribe